Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) EBT: 2023-2024

Historic EBT for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$88.0 million.

  • CG Oncology's EBT fell 114.22% to -$43.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.4 million, marking a year-over-year decrease of 107.99%. This contributed to the annual value of -$88.0 million for FY2024, which is 81.36% down from last year.
  • As of FY2024, CG Oncology's EBT stood at -$88.0 million, which was down 81.36% from -$48.5 million recorded in FY2023.
  • CG Oncology's EBT's 5-year high stood at -$48.5 million during FY2023, with a 5-year trough of -$88.0 million in FY2024.
  • Its 2-year average for EBT is -$68.3 million, with a median of -$68.3 million in 2023.
  • Data for CG Oncology's EBT shows a maximum YoY tumbled of 81.36% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's EBT (Yearly) stood at -$48.5 million in 2023, then plummeted by 81.36% to -$88.0 million in 2024.